24/7 Patient Assistance: 760-405-8205

Samuel J. Klempner, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated

  • Bio & Insurance Information

    Dr. Samuel Klempner graduated from the University of Massachusetts Medical School and completed his residency program at the Brigham and Women's Hospital. Then, he did a fellowship at the Beth Israel Deaconess Medical Center. He is specialized in Medical Oncology and is board certified in Internal Medicine, Hematology and Oncology. Dr. Klempner has been in practice for more than 6 years and is affiliated with the Brigham and Women's Hospital and Cedar-Sinai Medical Center. During his career, he has also contributed to several clinical research publications.


  • Education & Training

    dept_icon

    University of Massachusetts Medical School

    Medical School

    dept_icon

    Brigham and Women\'s Hospital

    Residency

    dept_icon

    Beth Israel Deaconess Medical Center

    Fellowship

  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Hematology

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Brigham and Women's Hospital

    Languages: English/Spanish

    (617) 732-5500

    75 Francis St

    Boston, Maryland 02115

    Read More

    Cedars-Sinai Medical Center

    Languages: English/Spanish

    (310) 423-3277

    8700 Beverly Blvd

    Los Angeles, California 90048

    Read More
  • Publications & Memberships

    Dr. Samuel J. Klempner has contributed to 3 publications.

    Bone mineral density loss in thoracic and lumbar vertebrae following radiation for abdominal cancers.

    Wei, R. L.,Jung, B. C.,Manzano, W.,Sehgal, V.,Klempner, S. J.,Lee, S. P.,Ramsinghani, N. S.,Lall, C.; Radiother Oncol. 1900 Jan 01.

    See more >>

    A novel acquired ALK F1245C mutation confers resistance to crizotinib in ALK-positive NSCLC but is sensitive to ceritinib.

    Kodityal, S.,Elvin, J. A.,Squillace, R.,Agarwal, N.,Miller, V. A.,Ali, S. M.,Klempner, S. J.,Ou, S. H.; Lung Cancer. 2016 Jan 19.

    See more >>

    Targeting the MET Pathway in Gastric and Oesophageal Cancers: Refining the Optimal Approach.

    Lee, J.,Tran, P.,Klempner, S. J.; Clin Oncol (R Coll Radiol). 2016 Feb 18.

    See more >>

    Memberships

    Alpha Omega Alpha Honor Medical Society

    American Association for Cancer Research

    American Society of Clinical Oncology